219 Followers on Owler

Sage Therapeutics

 is a biotechnology firm that develops and commercializes novel therapies for the treatment of CNS and neurodegenerative disorders... Read more
OverviewCompetitorsFundingNews & Insights

Sage Therapeutics

 is a biotechnology firm that develops and commercializes novel therapies for the treatment of CNS and neurodegenerative disorders... Read more
Sage Therapeutics CEO: Barry E. Greene

CEO

Barry E. Greene

CEO Approval Rating

83/100

2010

PublicIndependent CompanyNASDAQSAGE

Pharmaceuticals & Biotechnology
Biotechnology
28342836 NAICS listing

Annual Revenue
$41.2M
Employees
690
Funding
$843M

News

Conference Presentation
Jan 08, 2025
Benzinga
Sage Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025
Layoffs
Oct 17, 2024
BioSpace
Sage Therapeutics Will Lay Off 33% of Employees, Including Over Half of R&D

Sage Therapeutics Competitors

1Praxis
2Axsome
See 2+ competitors

Trending Companies